<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03143738</url>
  </required_header>
  <id_info>
    <org_study_id>KE-0254/188/2016</org_study_id>
    <nct_id>NCT03143738</nct_id>
  </id_info>
  <brief_title>Comparison of Regional Anesthesia Techniques After Total Knee Arthroplasty</brief_title>
  <official_title>Continuous Adductor Canal Block in Comparison to Continuous Femoral Nerve Block in Patients After Total Knee Arthroplasty: Randomized Control Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Konskie Specjalist Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Lublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of continuous adductor canal block to continuous femoral nerve block in patients
      after total knee arthroplasty.

      All patients will be anesthetized with spinal anesthesia. Continuous infusion of ropivacaine
      with a catheter implemented to the adductor canal or next to the femoral nerve.

      The observed goals: pain intensity, the beginning and quality of rehabilitation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Written consent will be obtained a day before the surgery. Only subarachnoidally
      anaesthetised patients may participate in the study. Pencil-point spinal needle and
      bupivacaine (Marcaine Heavy Spinal 0.5 %) will be used.

      Before the beginning of operation, under ultrasound control, a catheter will be implemented
      to one of the chosen position: the adductor canal (the middle or lower third of thigh) or
      near the femoral nerve (below the inguinal ligament). The local anesthetic solution of 0.2 %
      ropivacaine will be started with an elastomeric pump (5 mL per hour, up to 72 hours) as soon
      as a catheter in the right position.

      The pain will be measured with VAS (visual-analogue scale) 4, 8, 12, 24 and 48 hours after
      the end of operation. At the same time, i.e.: 4, 8, 12, 24 and 48 hours from the end of
      surgery, the range of flexion and extension in the operated knee will be assessed. Moreover,
      the possibility of patient's sitting, standing up and walking will be noted.

      All parameters will be reassessed before patients' discharge from the hospital. Each patient
      will receive paracetamol (1.0) and metamizol (1.0) intravenously (i.v.) q6h. 5 mg of morphine
      may be given as required, up to 2 dosages per day as a rescue medication.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 24, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups of patients randomly allocated: adductor canal group or femoral nerve group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants not aware of the type of continuous blockade.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The change of acute postoperative pain</measure>
    <time_frame>4, 8, 12, 24, 48 hours from the end of surgery</time_frame>
    <description>Measured in rest with VAS (visual-analogue scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee flexion</measure>
    <time_frame>4, 8, 12, 24, 48 hours from the end of surgery</time_frame>
    <description>range of flexion in operated knee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee extension</measure>
    <time_frame>4, 8, 12, 24, 48 hours from the end of surgery</time_frame>
    <description>range of extension in operated knee</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain, Acute</condition>
  <condition>Knee Arthropathy</condition>
  <condition>Postoperative Pain</condition>
  <condition>Mobility Limitation</condition>
  <arm_group>
    <arm_group_label>continuous anesthesia of adductor canal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous anesthesia of femoral nerve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous anesthesia of adductor canal</intervention_name>
    <description>After subarachnoid anesthesia, but before the beginning of surgery, a catheter will be implemented to the adductor canal and infusion of 5 mL/h of 0.2 % ropivacaine will be started.</description>
    <arm_group_label>continuous anesthesia of adductor canal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous anesthesia of femoral nerve</intervention_name>
    <description>After subarachnoid anesthesia, but before the beginning of surgery, a catheter will be implemented next to the femoral nerve (below inguinal ligament) and infusion of 5 mL/h of 0.2 % ropivacaine will be started.</description>
    <arm_group_label>continuous anesthesia of femoral nerve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal anesthesia</intervention_name>
    <description>Before the beginning of surgery all patients will be anesthetised with 0.5 % hyperbaric bupivacaine (Marcaine Heavy), 2.0 - 2.5 mL solution. Pencil point spinal needle will be used.</description>
    <arm_group_label>continuous anesthesia of adductor canal</arm_group_label>
    <arm_group_label>continuous anesthesia of femoral nerve</arm_group_label>
    <other_name>Subarachnoid anesthesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  knee arthroplasty

          -  obtained consent

          -  subarachnoid anaesthesia

        Exclusion Criteria:

          -  coagulopathy

          -  allergy to to local anesthetics

          -  depression, antidepressant drugs treatment

          -  epilepsy

          -  usage of painkiller before surgery

          -  addiction to alcohol or recreational drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michał Borys, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Lublin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michał Borys, M.D., PhD</last_name>
    <phone>+48506350569</phone>
    <email>michalborys1@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miroslaw Czuczwar, M.D., PhD</last_name>
    <phone>+48509390985</phone>
    <email>czuczwarm@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Michał Borys</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michał Borys, M.D. Ph.D</last_name>
      <phone>506350569</phone>
      <email>michalborys1@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Miroslaw Czuczwar, M.D., Ph.D</last_name>
      <phone>+48509390985</phone>
      <email>czuczwarm@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2017</study_first_submitted>
  <study_first_submitted_qc>May 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lublin</investigator_affiliation>
    <investigator_full_name>Michał Borys</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>regional anesthesia</keyword>
  <keyword>knee replacement</keyword>
  <keyword>pain treatment</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Mobility Limitation</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

